These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23114512)

  • 1. Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial.
    Pines HA; Gorbach PM; Weiss RE; Hess K; Murphy R; Saunders T; Brown J; Anton PA; Cranston RD
    AIDS Behav; 2013 Mar; 17(3):1002-15. PubMed ID: 23114512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal-specific microbicide applicator: evaluation and comparison with a vaginal applicator used rectally.
    Carballo-Diéguez A; Giguere R; Dolezal C; Bauermeister J; Leu CS; Valladares J; Rohan LC; Anton PA; Cranston RD; Febo I; Mayer K; McGowan I
    AIDS Behav; 2014 Sep; 18(9):1734-45. PubMed ID: 24858481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035).
    Bauermeister JA; Dominguez Islas C; Jiao Y; Tingler R; Brown E; Zemanek J; Giguere R; Balan I; Johnson S; Macagna N; Lucas J; Rose M; Jacobson C; Collins C; Livant E; Singh D; Ho K; Hoesley C; Liu A; Kayange N; Palanee-Phillips T; Chariyalertsak S; Gonzales P; Piper J;
    PLoS One; 2023; 18(4):e0284339. PubMed ID: 37043527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Condoms, Lubricants and Rectal Cleansing: Practices Associated with Heterosexual Penile-Anal Intercourse Amongst Participants in an HIV Prevention Trial in South Africa, Uganda and Zimbabwe.
    Duby Z; Hartmann M; Montgomery ET; Colvin CJ; Mensch B; van der Straten A
    AIDS Behav; 2016 Apr; 20(4):754-62. PubMed ID: 26126586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men.
    Carballo-Diéguez A; Dolezal C; Bauermeister JA; O'Brien W; Ventuneac A; Mayer K
    Sex Transm Infect; 2008 Nov; 84(6):483-7. PubMed ID: 19028952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, patterns, and preferences of lubricant use during anal intercourse within male sexual partnerships in Lima, Peru: implications for a rectal microbicide HIV prevention intervention.
    Clark JL; Salvatierra HJ; Segura ER; Salazar X; Konda K; Galea J; Klausner JD; Coates TJ; Caceres CF
    AIDS Care; 2013; 25(5):579-85. PubMed ID: 23082796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Supporting and Hindering Adherence to Rectal Microbicide Gel Use with Receptive Anal Intercourse in a Phase 2 Trial.
    Giguere R; Rael CT; Sheinfil A; Balán IC; Brown W; Ho T; Dolezal C; Leu CS; Liu A; Mayer KH; Lama JR; McGowan I; Carballo-Diéguez A; Cranston RD;
    AIDS Behav; 2018 Feb; 22(2):388-401. PubMed ID: 28825142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator Satisfaction Among Young Men Who Have Sex With Men.
    Bauermeister J; Giguere R; Dolezal C; Leu CS; Febo I; Cranston RD; Mayer K; McGowan I; Carballo-Diéguez A
    AIDS Educ Prev; 2016 Feb; 28(1):1-10. PubMed ID: 26829253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A latent trajectory analysis of young sexual and gender minorities' adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial).
    Choi SK; Bauermeister J; Tingler RC; Johnson S; Macagna N; Ho K; Hoesley C; Liu A; Kayange N; Palanee-Phillips T; Chariyalertsak S; Gonzales P; Piper JM;
    BMC Public Health; 2023 Dec; 23(1):2464. PubMed ID: 38066471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preference and practices relating to lubricant use during anal intercourse: implications for rectal microbicides.
    Javanbakht M; Murphy R; Gorbach P; LeBlanc MA; Pickett J
    Sex Health; 2010 Jun; 7(2):193-8. PubMed ID: 20465986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of Rectal Product Use and Country of Residence Influence Preference for Rectal Microbicide Dosage Forms Among Young Sexual and Gender Minorities: A Multi-country Trial Comparing Placebo Douche, Suppository, and Insert Products.
    Giguere R; Balán IC; Kutner BA; Choi SK; Tingler R; Johnson S; Macagna N; Webster J; Liu A; Chariyalertsak S; Hoesley C; Gonzales P; Ho K; Kayange N; Palanee-Phillips T; Brown E; Zemanek J; Jacobson CE; Doncel GF; Piper J; Bauermeister JA;
    AIDS Behav; 2024 Aug; 28(8):2577-2589. PubMed ID: 38740628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Like Holding an Umbrella Before It Rains": Acceptability of Future Rectal Microbicides Among Men Who Have Sex With Men in India-A Modified Technology Acceptance Model.
    Chakrapani V; Newman PA; Shunmugam M; Mengle S; Nelson R; Rubincam C; Kumar P
    Qual Health Res; 2017 Jul; 27(8):1236-1248. PubMed ID: 28682740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using conjoint analysis to measure the acceptability of rectal microbicides among men who have sex with men in four South American cities.
    Kinsler JJ; Cunningham WE; Nureña CR; Nadjat-Haiem C; Grinsztejn B; Casapia M; Montoya-Herrera O; Sánchez J; Galea JT
    AIDS Behav; 2012 Aug; 16(6):1436-47. PubMed ID: 21959986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.
    Rosen RK; Morrow KM; Carballo-Diéguez A; Mantell JE; Hoffman S; Gai F; Maslankowski L; El-Sadr WM; Mayer KH
    J Womens Health (Larchmt); 2008 Apr; 17(3):383-92. PubMed ID: 18328009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothetical Rectal Microbicide Acceptability and Factors Influencing It among Men Who Have Sex with Men in Tianjin, China.
    Zhang G; Zhang H; Yu H; Zhao Z; Yang J; Zhang M; Zhang M
    PLoS One; 2016; 11(5):e0156561. PubMed ID: 27243457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche.
    Carballo-Dieguez A; Giguere R; Lentz C; Dolezal C; Fuchs EJ; Hendrix CW
    AIDS Behav; 2019 Jun; 23(6):1484-1493. PubMed ID: 30415431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates.
    Leyva F; Fuchs EJ; Bakshi R; Carballo-Dieguez A; Ventuneac A; Yue C; Caffo B; Du Y; Torbenson M; Li L; Mullin G; Lee L; Rohan L; Anton PA; Hendrix CW
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1089-97. PubMed ID: 26066390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lubricant use among men who have sex with men reporting receptive anal intercourse in Peru: implications for rectal microbicides as an HIV prevention strategy.
    Kinsler JJ; Galea JT; Peinado J; Segura P; Montano SM; Sánchez J
    Int J STD AIDS; 2010 Aug; 21(8):567-72. PubMed ID: 20975090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using conjoint analysis to determine the impact of product and user characteristics on acceptability of rectal microbicides for HIV prevention among Peruvian men who have sex with men.
    Tang EC; Galea JT; Kinsler JJ; Gonzales P; Sobieszczyk ME; Sanchez J; Lama JR
    Sex Transm Infect; 2016 May; 92(3):200-5. PubMed ID: 26574569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse.
    Frasca T; Giguere R; Ibitoye M; Dolezal C; Febo I; Cranston RD; Mayer K; McGowan I; Carballo-Diéguez A
    Arch Sex Behav; 2017 May; 46(4):1101-1109. PubMed ID: 27129533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.